Cite
Philippin H, Matayan E, Knoll KM, et al. Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial. Lancet Glob Health. 2021;9(11):e1589-e1599doi: 10.1016/S2214-109X(21)00348-X.
Philippin, H., Matayan, E., Knoll, K. M., Macha, E., Mbishi, S., Makupa, A., Matsinhe, C., da Gama, V., Monjane, M., Ncheda, A. J., Mulobuana, F. A., Muna, E., Fopoussi, N., Gazzard, G., Marques, A. P., Shah, P., Macleod, D., Makupa, W. U., & Burton, M. J. (2021). Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial. The Lancet. Global health, 9(11), e1589-e1599. https://doi.org/10.1016/S2214-109X(21)00348-X
Philippin, Heiko, et al. "Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial." The Lancet. Global health vol. 9,11 (2021): e1589-e1599. doi: https://doi.org/10.1016/S2214-109X(21)00348-X
Philippin H, Matayan E, Knoll KM, Macha E, Mbishi S, Makupa A, Matsinhe C, da Gama V, Monjane M, Ncheda AJ, Mulobuana FA, Muna E, Fopoussi N, Gazzard G, Marques AP, Shah P, Macleod D, Makupa WU, Burton MJ. Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial. Lancet Glob Health. 2021 Nov;9(11):e1589-e1599. doi: 10.1016/S2214-109X(21)00348-X. Epub 2021 Oct 13. PMID: 34655547; PMCID: PMC8526362.
Copy
Download .nbib